- AdventHealth
AdventHealth Neuroscience Institute’s (NSI) spine surgery programs at Orlando, Altamonte and Celebration recently became the first in Florida and three of the first 16 in the country to earn Spine Surgery Center of Excellence certification from DNV, a worldwide, independent certification body. The DNV survey includes evaluation of 256 data points as well as an in-person survey. It focuses on evaluating processes across the continuum of care that contribute to positive outcomes and support performance improvement. Earning certification validates that a facility meets or exceeds standards of care in spine surgery.
“Our goal is to be recognized as a national, leading spine center of excellence, and the DNV designation is validation that we are on the right track,” explains Chetan K. Patel, MD, Executive Medical Director, Spine, AdventHealth NSI.
Optimizing Spine Surgery Outcomes
Over the past three years, AdventHealth NSI developed and implemented a new multidisciplinary spine surgery pathway that was constructed based on an extensive review of available evidence and best practices along with implementation of an ongoing process improvement infrastructure.
“We focus on addressing all of the modifiable risk factors that could impact a patient’s surgical success,” says Dr. Patel.
The pathway involves the entire spine surgery care team and includes pre-surgical patient optimization and education, evidence-based perioperative care, and post-surgical communication and connection. The ultimate goal is to enhance the value of the spine care provided to patients by delivering better outcomes at a lower cost.
For example, recent evidence shows that malnutrition is an often underdiagnosed condition leading to poor outcomes in spine surgery patients. As a result, the AdventHealth NSI spine team implemented a regimen of nutritional supplements both before and after surgery to optimize surgical healing. In addition, to enhance convenience, increase attendance and mitigate patients’ COVID-19 safety concerns, they also now offer a virtual version of their spine pre-surgical education class.
“We are on a never-ending journey of delivering the best outcomes in the care of spinal pathology,” shares Dr. Patel. “We achieve this by objectively measuring and tracking the quality of our outcomes and then implementing processes that allow us to deliver the best outcome for every patient, every time. DNV conducted a thorough audit of our program and its processes, certifying that our approach has indeed led to better outcomes.”
Being part of DNV also provides the AdventHealth NSI spine surgery team with ongoing access to how quality is being defined and measured at other leading centers of excellence across the country as well as best practices they are deploying to improve outcomes.
“We believe in forever getting better,” concludes Dr. Patel. “That means we are always measuring, evaluating, learning and improving. Ultimately, it is about having the greatest possible impact on our local community and each one of the patients we serve.”
To learn more about this accreditation and how it can help your patients, contact one of our Spine Health care coordinators at CFD-S.CareCoordinator@AdventHealth.com.
Recent News
AdventHealth Cancer Institute Advances the Use of CAR T-Cell Therapy for Multiple Myeloma
CAR-T therapies have emerged as new treatment options for certain types of cancer through a one-time infusion that can lead to long-lasting remission.
AdventHealth Graduate Medical Education Program Celebrates 50 Years
Growing from a family practice residency to 24 accredited programs, AdventHealth’s Graduate Medical Education (GME) program celebrates 50 years.
New Clinical Trial Explores Digital Intervention for Apathy in Late-life Depression
Afflicting 30-50% of patients with late-life depression, apathy is a challenging psychiatric syndrome in older adulthood that can result in lack of motivation leading to poor self-care, physical...
AdventHealth Performs Central Florida’s First Liver Transplant for Unresectable Colorectal Liver Metastases
In June 2025, AdventHealth Abdominal Transplant Surgeon and Surgical Oncologist Ryan Day, MD, worked with a multidisciplinary team to perform Central Florida’s first liver transplant for unresectable...
AdventHealth Neuroscience Institute First in Florida to be Recognized as a GammaTile Center of Excellence
GammaTile is the first and only tile-based radiation therapy for the treatment of
operable brain tumors. The AdventHealth Neuroscience Institute began performing GammaTile procedures in 2021 and was...
An AdventHealth Collaboration Explores the Impact of Microgravity and Electrical Stimulation on Muscle Cell Health in Space
Using a muscle lab-on-chip model aboard the International Space Station (ISS), AdventHealth Translational Research Institute’s Dr. Paul Coen has been working with a multidisciplinary team from the...
AdventHealth Neuroscience Institute Among First in U.S. to Offer Phase IIa Clinical Trial of Troculeucel for Moderate Alzheimer’s Disease
While most clinical trials for Alzheimer’s disease have focused on patients with early or mild cognitive impairment, roughly 30% of those with Alzheimer’s have moderate stage disease for which there...
AdventHealth Translational Research Institute Selected as Clinical Site for National Study of Muscle, Mobility and Aging (SOMMA)
Under the leadership of Scientific Director and Principal Investigator Bret H. Goodpaster, PhD, the AdventHealth Translational Research Institute (TRI) is now enrolling men and women 70 years of age...
AdventHealth Neuroscience Institute Administers First Dose of Investigative NK Cell Therapy to Person with Alzheimer’s Disease
Under a single compassionate use Investigational New Drug (IND) authorization cleared by the U.S. Food and Drug Administration (FDA), the AdventHealth Neuroscience Institute worked with NKGen Biotech...
New Study Published in the New England Journal of Medicine Shows the Addition of Regional Nodal Irradiation Does Not Decrease Rate of Invasive Breast Cancer Recurrence in Patients with Negative Axillary Nodes Following Neoadjuvant Chemotherapy
Findings of the phase III, multicenter, randomized NSABP B-51-RTOG 1304 clinical trial were recently published in the New England Journal of Medicine with AdventHealth Cancer Institute’s Dr. Mamounas...
AdventHealth Study Exploring the Use of MR-Guided Focused Ultrasound (MRgFUS) to Disrupt the Blood-Brain Barrier for Treatment of Alzheimer’s Disease
Under the leadership of Dr. Valeria Baldivieso and Dr. Chandan Reddy, the AdventHealth Research Institute is the first and only site in Orlando offering the Exablate Blood-Brain Barrier (BBB)...
AdventHealth Research Institute Offers Phase II Clinical Trial of Etanercept for Treatment of Blast-Induced Tinnitus
Approximately 1 billion people throughout the world suffer from tinnitus (ringing in the ears), and it is the number one disability of those who serve in the U.S. military. The condition can disrupt...